Matches in SemOpenAlex for { <https://semopenalex.org/work/W2506766336> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- W2506766336 endingPage "102" @default.
- W2506766336 startingPage "61" @default.
- W2506766336 abstract "Involving humans in experimental procedures or medical research involves possible benefit and risk, and in regulating such activities three interests are usually involved: the recipient's, the professional's, and advancing medicine and science. With xenotransplantation the public interest is also engaged. When regulating any biotechnology these interests must be recognised and regulation usually takes two forms: the general regulatory framework applying to any experimental procedure and medical research, and any additional systems governing specific biotechnologies. The latter is considered in Chapter 4; here I explore how experimental procedures and medical research are defined, regulated and into which category genetically engineered solid organ xenotransplants fall. The regulatory schemes in England are used as an example of the problems which may be encountered when trying to regulate a developing biotechnology. I also draw on Australian, Canadian, New Zealand and the US schemes where relevant, and consider whether the current regimes are appropriate given the risks of xenotransplantation. To what extent is xenotransplantation on the general ‘regulatory radar’? Knowing how an activity is classified is important as this affects the regulatory scheme to be followed and how and which recipients can be selected. I explore the legal provisions and ethical guidance on selecting recipients, and whether these offer appropriate parameters for experimenters/researchers and potential recipients. Can and should a competent, desperately or terminally ill patient with little or ‘no other hope’ be able to receive the first genetically engineered solid organ xenotransplant, as has been suggested? The risk is that desperately ill patients with no other hope will be used as research tools because of their understandable willingness to rely on remote chances of benefit. I consider the protection offered to potential xeno-recipients, and introduce some of the issues explored further in Chapter 5 relating to the principle of autonomy. Should people be allowed to sacrifice themselves in the (limited) hope of gaining some benefit for themselves, but with the more likely outcome being providing information for future generations, especially when the risks go beyond the potential beneficiary? Who receives a genetically engineered solid organ xenotransplant is important as there is a consensus that the risks necessitate recipients, and others, to agree to and comply with surveillance regimes, and if recipients are unable or unwilling to comply with these requirements public health may be jeopardised." @default.
- W2506766336 created "2016-08-23" @default.
- W2506766336 creator A5042244822 @default.
- W2506766336 date "2011-12-14" @default.
- W2506766336 modified "2023-09-23" @default.
- W2506766336 title "Regulating experimental procedures and medical research" @default.
- W2506766336 doi "https://doi.org/10.1017/cbo9781139026925.003" @default.
- W2506766336 hasPublicationYear "2011" @default.
- W2506766336 type Work @default.
- W2506766336 sameAs 2506766336 @default.
- W2506766336 citedByCount "0" @default.
- W2506766336 crossrefType "book-chapter" @default.
- W2506766336 hasAuthorship W2506766336A5042244822 @default.
- W2506766336 hasConcept C112930515 @default.
- W2506766336 hasConcept C127413603 @default.
- W2506766336 hasConcept C141071460 @default.
- W2506766336 hasConcept C144024400 @default.
- W2506766336 hasConcept C17744445 @default.
- W2506766336 hasConcept C190253527 @default.
- W2506766336 hasConcept C2778442404 @default.
- W2506766336 hasConcept C2911091166 @default.
- W2506766336 hasConcept C55587333 @default.
- W2506766336 hasConcept C71924100 @default.
- W2506766336 hasConceptScore W2506766336C112930515 @default.
- W2506766336 hasConceptScore W2506766336C127413603 @default.
- W2506766336 hasConceptScore W2506766336C141071460 @default.
- W2506766336 hasConceptScore W2506766336C144024400 @default.
- W2506766336 hasConceptScore W2506766336C17744445 @default.
- W2506766336 hasConceptScore W2506766336C190253527 @default.
- W2506766336 hasConceptScore W2506766336C2778442404 @default.
- W2506766336 hasConceptScore W2506766336C2911091166 @default.
- W2506766336 hasConceptScore W2506766336C55587333 @default.
- W2506766336 hasConceptScore W2506766336C71924100 @default.
- W2506766336 hasLocation W25067663361 @default.
- W2506766336 hasOpenAccess W2506766336 @default.
- W2506766336 hasPrimaryLocation W25067663361 @default.
- W2506766336 hasRelatedWork W2465979655 @default.
- W2506766336 hasRelatedWork W73330790 @default.
- W2506766336 isParatext "false" @default.
- W2506766336 isRetracted "false" @default.
- W2506766336 magId "2506766336" @default.
- W2506766336 workType "book-chapter" @default.